Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reduction of gastric hypersecretion in Zollinger-Ellison syndrome with omeprazole.

× No keyword cloud information.

7 in total

1. Effects of single daily doses of a pyridil-2-tetrahydrothiophene derivative (40749 RP) on 24 hour H+ activity, nocturnal acid output, gastrin and pepsinogen I profiles in duodenal ulcer patients.

Authors: P J Malè; M Griessen; M G Cunningham; A M Frydman; N A Garoflid-Oprescu; R De Peyer; E Loizeau
Journal: Gut Date: 1986-04 Impact factor: 23.059

2. Influence of chronic omeprazole treatment on gastric endocrine function.

Authors: H Koop; H Schwarting; A Knorr-Marin; C Willhardt; T Möser; R Arnold
Journal: Klin Wochenschr Date: 1987-02-16

Review 3. Use of omeprazole in patients with Zollinger-Ellison syndrome.

Authors: H Frucht; P N Maton; R T Jensen
Journal: Dig Dis Sci Date: 1991-04 Impact factor: 3.199

Review 4. Clinical pharmacology of omeprazole.

Authors: C W Howden
Journal: Clin Pharmacokinet Date: 1991-01 Impact factor: 6.447

5. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.

Authors: C W Howden; J A Forrest; J L Reid
Journal: Gut Date: 1984-07 Impact factor: 23.059

Review 6. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors: S P Clissold; D M Campoli-Richards
Journal: Drugs Date: 1986-07 Impact factor: 9.546

7. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.

Authors: D C Metz; J R Pisegna; G L Ringham; K Feigenbaum; P D Koviack; P N Maton; J D Gardner; R T Jensen
Journal: Dig Dis Sci Date: 1993-02 Impact factor: 3.199

7 in total